JD Orgochem Limited (524592) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of JD Orgochem Limited ₹19.08, price ₹16.25, upside +17.4%, quality 48 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch JD Orgochem Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹2.59 – ₹28.35 · fair‑value band ₹17.59 – ₹22.34 · the ₹16.25 price screens below the ₹19.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 2 fiscal years are left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 27, 2026.
Follow JD Orgochem in your weekly email
Every Wednesday you see whether JD Orgochem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
JD Orgochem Limited engages in manufacturing and trading dyes, dye intermediates, and pigments in India. It serves textile, plastic, printing ink, and paint industries. The company was formerly known as Jaysynth Dyechem Ltd. and changed its name to JD Orgochem Limited in December 2003.
Show more
JD Orgochem Limited engages in manufacturing and trading dyes, dye intermediates, and pigments in India. It serves textile, plastic, printing ink, and paint industries. The company was formerly known as Jaysynth Dyechem Ltd. and changed its name to JD Orgochem Limited in December 2003. JD Orgochem Limited was incorporated in 1973 and is headquartered in Mumbai, India.
Stock analysis
JD Orgochem Limited (524592) currently trades at ₹16.25, while our model-based Fair Value estimate is ₹19.08, implying the stock looks roughly 14.8% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹48.33 per share, and 10 of the 17 models we run sit above the ₹16.25 price.
Bear case: the Dividend Discount group reads lowest at ₹2.24, and 7 of the 17 models stay below the price. Evidence for this calculation is low.
Scenario range: ₹17.59 (bear) to ₹22.34 (bull), the price of ₹16.25 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
JD Orgochem Limited reported revenue of ₹2.6B in FY2026 versus ₹14.6M in FY2022, a compound +265.1%/yr. Reported net income was ₹147M in FY2026.
Key figures
Market cap ₹54.1M (≈ $561K) · EPS (TTM) ₹−0.8600 · Net margin 5.6% · Return on assets (EBIT) −0.2% · Free cash flow −₹141M · Net debt ₹390M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 68% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −24% fair-value upside, at 17%, 524592 screens cheaper than that median.
Fair Value models
Bear ₹17.59Fair Value ₹19.08Bull ₹22.34
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.49/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+13.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+541.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+191.6%
Start year 2021 (pandemic). Over 10 years: +77.8% a year
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+68.6%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 3 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 3 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−51.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−51.1%
Dividend (yield on the price)0.0%
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−107% → 7%
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Chemicals · 341 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is JD Orgochem Limited (524592) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹19.08 versus a price of ₹16.25, about +17% upside (undervalued).
What is the fair value of 524592?
Our model-based fair value for JD Orgochem Limited is ₹19.08 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹16.25.
What is the quality score of 524592?
JD Orgochem Limited has a Quality Score of 48/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for JD Orgochem Limited (524592)?
Our model-based price target is the fair value of ₹19.08 (as of Sep 27, 2026) from 17 valuation models. Cautious scenario ₹17.59, optimistic scenario ₹22.34. It is a calculation from audited fundamentals, not an analyst target.
What is the JD Orgochem Limited stock forecast for 2026?
Our models put fair value at ₹19.08, about +17% upside versus a price of ₹16.25 (undervalued). Cautious scenario ₹17.59, optimistic scenario ₹22.34. The calculation is refreshed regularly with new filings.
What is the intrinsic value of JD Orgochem Limited (524592)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For JD Orgochem Limited it is ₹19.08 per share (as of Sep 27, 2026), against a price of ₹16.25. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is JD Orgochem Limited stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 524592 trades below its calculated fair value: price ₹16.25, fair value ₹19.08, a gap of about +17% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 524592?
No. The price is what the market pays today (₹16.25); the fair value is what the company's own numbers justify (₹19.08). For JD Orgochem Limited the two are ₹2.83 per share apart. That gap is exactly why we show both numbers side by side.
How much is JD Orgochem Limited worth?
The market values JD Orgochem Limited at about ₹54.1M (market capitalisation, as of Sep 27, 2026). Per share that is ₹16.25; our models calculate a fair value of ₹19.08 per share.
What do the bullish and bearish scenarios say about 524592?
Our models span a range for JD Orgochem Limited: cautious scenario ₹17.59, base ₹19.08, optimistic ₹22.34 per share (as of Sep 27, 2026, price ₹16.25). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of JD Orgochem Limited (524592)?
Balance-sheet figures for JD Orgochem Limited (as of Sep 27, 2026): debt of 0.25 per unit of equity. They feed the Quality Score of 48/100, which measures business quality independently of the share price.
How far is 524592 from its 52-week high?
JD Orgochem Limited trades at ₹16.25, about 22% below its 52-week high of ₹20.72 and 68% above the low of ₹9.67 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹19.08 is for.
Which stocks are comparable to JD Orgochem Limited?
From the same area (Basic Materials) we also value Ningxia Baofeng Energy Group, Dow Inc, Hengli Petrochemical Co, Zangge Mining Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is JD Orgochem Limited stock attractive at the current price?
The data as of Sep 27, 2026: price ₹16.25, calculated fair value ₹19.08 (+17%), Quality Score 48/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 524592 calculated?
We run JD Orgochem Limited through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹19.08, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. JD Orgochem Limited currently trades 15 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of JD Orgochem Limited (524592)?
The closing price on Oct 1, 2026 was ₹16.25. Our model-based fair value is ₹19.08, about +17% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with JD Orgochem Limited right now?
The price is below even our cautious bear case (₹17.59). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of JD Orgochem Limited
How large is the market capitalisation of JD Orgochem Limited (524592)?
The market capitalisation of JD Orgochem Limited is ₹54.1M (≈ $561K). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of JD Orgochem Limited (524592)?
Earnings per share at JD Orgochem Limited are ₹−0.8600. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of JD Orgochem Limited (524592)?
The net margin of JD Orgochem Limited is 5.6% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of JD Orgochem Limited (524592)?
On an EBIT basis the return on assets of JD Orgochem Limited is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does JD Orgochem Limited (524592) generate?
The free cash flow of JD Orgochem Limited is −₹141M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does JD Orgochem Limited (524592) carry?
The net debt of JD Orgochem Limited is ₹390M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch JD Orgochem Limited in the live analysis
One click puts JD Orgochem Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
